Rheumatology Doctors in Burlington, VT Accepting Medicare

8 Rheumatology doctors found. Showing 1 - 8

Dr. Bonita Sandra Libman, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, East Pavilion Level 5 Rheumatology, Burlington, VT 05401 Phone: 802-847-4574    Fax: 802-847-9695

Dr. Sheldon Mark Cooper, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, East Pavilion Level 5 Rheumatology, Burlington, VT 05401 Phone: 802-847-4574

Jeanne Gosselin, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Avenue, East Pavilion Level 5, Burlington, VT 05401 Phone: 802-847-4574

Dr. Christine Haas Jones, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Level 5 East Pavilion, Burlington, VT 05401 Phone: 802-847-4574    Fax: 802-847-9695

Dr. Edward Samuel Leib, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, East Pavilion Level 5, Rheumatology, Burlington, VT 05401 Phone: 802-847-4574

Dr. Scott Daniel Legunn, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave., Uvm Medical Center - Medicine/rheumatology, Burlington, VT 05401 Phone: 802-847-4574    Fax: 802-847-9695

Dr. Ralph C Budd, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, East Pavillion Level 5 Rheumatology, Burlington, VT 05401 Phone: 802-847-4574    Fax: 802-847-9695

Dr. Chi Chi Lau, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, East Pavilion, Level 5, Rheumatology, Burlington, VT 05401 Phone: 802-847-4574    Fax: 802-847-9695

News Archive

Phase III trial: Rolapitant lessens chemotherapy-induced nausea and vomiting

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.

Otsuka Pharmaceutical enters into global agreement with Columbia University School of Public Health

Otsuka Pharmaceutical Development & Commercialization, Inc., announced an agreement with research experts from the Columbia University Irving Center Vagelos College of Physicians and Surgeons and Mailman School of Public Health to help support the epidemiological needs of Otsuka Global Pharmacovigilance (GPV) for products, enhanced training, and employee education.

Six early-career researchers to receive Heinz Maier-Leibnitz Prize

The new recipients of the most important prize for early-career researchers in Germany have been announced. The selection committee, appointed by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) and the German Federal Ministry of Education and Research (BMBF), has chosen three young men and three young women to receive the Heinz Maier-Leibnitz Prize 2012.

VA to probe alleged cover-up of Minneapolis patient's death

The VA is investigating allegations that the appointment records of a retired Marine who died after having seizures were falsified to cover up delays in care at the Minneapolis VA Health Care System.

Identifying, preventing and treating drug-induced arrhythmias

Health care professionals should become more familiar with medications that cause irregular heart rhythms called arrhythmias, according to "Drug- Induced Arrhythmias," a new scientific statement from the American Heart Association, published today in the Association's flagship journal Circulation.

Read more Medical News

› Verified 1 days ago